先天性心脏病成人与儿童患者中经静脉导线所致三尖瓣反流的外科治疗
该研究分析了1998至2015年间54例因导线所致三尖瓣反流而接受三尖瓣手术的先天性心脏病连续患者,其中55.6%行修复、44.4%行置换。30天死亡率为1.9%,5年生存率总体为80.4%。修复组与置换组5年再干预风险相当,但修复组反流进展更明显,尤其在术前重度反流患者中。
要点
- 54例先心病患者因导线所致三尖瓣反流接受三尖瓣手术,30天死亡率为1.9%。
- 5年生存率总体为80.4%,修复组79.7%,置换组81.4%。
- 术前重度反流者5年估测中重度反流风险修复组74.4%,置换组10.7%。
核心结论
- 尽管多数患者需同期心脏手术,三尖瓣手术后早期死亡率低;修复与置换的生存率和再干预率相当,但修复与随访中期进行性三尖瓣反流相关,尤其术前重度反流患者。
研究设计与样本
- 回顾性分析1998至2015年54例连续因导线所致三尖瓣反流接受三尖瓣手术的先天性心脏病患者,采用Kaplan-Meier法或重复测量比例优势模型分析主要终点。
主要发现
- 患者中位年龄48.2岁(四分位距37.3-59.0岁),女性31例(57.4%),儿童2例(3.7%)。
- 30例行三尖瓣修复(55.6%),24例行置换(44.4%),52例接受同期心脏手术。
- 30天死亡率1.9%(修复组3.3%,置换组0.0%)。
- 5年生存率总体80.4%,修复组79.7%,置换组81.4%。
- 术前重度反流者5年随访时模型估测中重度反流风险修复组74.4%,置换组10.7%;两组反流均改善(各P < .001),置换组改善优于修复组(P < .001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to evaluate outcomes of surgical management of lead-induced tricuspid regurgitation (TR) in patients with congenital heart disease. METHODS: We analyzed data of 54 consecutive patients who underwent tricuspid valve (TV) surgery from 1998 to 2015 for lead-induced TR. Primary end points, including mortality, TV reinterventions, and longitudinal TR measurements, were analyzed with the Kaplan-Meier method or with repeated measures proportional odds modeling. RESULTS: The median age of patients was 48.2 years (interquartile range, 37.3-59.0 years); 31 (57.4%) were female; 2 (3.7%) were children. Thirty patients (55.6%) underwent TV repair and 24 (44.4%) had replacement, and 52 underwent concomitant cardiac procedures. Thirty-day mortality was 1.9% (repair: 3.3%, replacement: 0.0%). Five-year survival was 80.4% overall and 79.7% and 81.4% for the repair and replacement groups, respectively. In response to surgery, TR improved in both groups (each P < .001) but more with replacement than repair (P < .001); longitudinal analysis showed that TR trends observed early on favoring replacement were sustained across follow-up (P < .001). The model-estimated risk of moderate or severe TR at 5-year follow-up, conditional on having severe preoperative TR, was 74.4% for the repair and 10.7% for the replacement group. Five-year cumulative risk of TV reintervention was comparable for valve repair and replacement. CONCLUSIONS: Despite the need for concomitant cardiac procedures in most of the patients, early mortality was low after TV surgery. Survival and rate of TV reintervention were comparable for the repair and replacement groups. However, TV repair was associated with progressive TR during intermediate follow-up, especially in patients with severe preoperative TR.
引用
- Huang Y, Dearani JA, Lahr BD, et al. Surgical management of transvenous lead-induced tricuspid regurgitation in adult and pediatric patients with congenital heart disease. J Thorac Cardiovasc Surg. 2021. PMID: 34753592. doi:10.1016/j.jtcvs.2021.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。